{
  "id": 4658001,
  "title": "Simplified registration for medicines using domestically produced APIs requires clear implementation mechanism – opinion",
  "url": "https://urgent.news/2026/08/31/simplified-registration-for-medicines-using-domestically-produced",
  "topic": "world",
  "section": "World",
  "published": "2026-08-31T14:55:37.000Z",
  "source": {
    "name": "Interfax-Ukraine",
    "slug": "interfax-ukraine",
    "url": "https://en.interfax.com.ua/news/general/1197483.html"
  },
  "original_language": "en",
  "account": "The government's Action Plan proposes to simplify the registration process for medicines made from domestically sourced active pharmaceutical ingredients (APIs) as an incentive for API production development, according to Anatoliy Reder, CEO of Interchem pharmaceutical company. Reder emphasized the necessity of a transparent and clear regulatory mechanism for the initiative's successful implementation. He clarified that merely supporting manufacturers of finished pharmaceutical products using locally produced APIs is insufficient; a well-defined algorithm is essential. Reder highlighted that approximately 70% of Interchem's finished drug production currently relies on APIs manufactured within Ukraine, with Pharmchem (located in Sumy region) contributing further to this percentage, accounting for around 20%. Consequently, around 80% of Interchem's medicines are produced using Ukrainian APIs.",
  "summary": "The simplification of the registration process for medicines produced from domestically sourced active pharmaceutical ingredients (APIs), as outlined in the government’s Action Plan, will serve as an incentive for the development of API production, but will require a clearly defined implementation mechanism, according to CEO of the Interchem pharmaceutical company Anatoliy Reder.",
  "key_points": [
    "Government's Action Plan aims to simplify registration for domestically produced medicines.",
    "Clear regulatory mechanism essential for successful implementation, says Interchem CEO.",
    "80% of Interchem's medicines currently rely on Ukrainian APIs."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}